This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Edward Htun-Van Der Horst: Innovator in Pharmaceutical Composition
Introduction
Edward Htun-Van Der Horst is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for HER3 activity. His work is crucial in the diagnosis, prevention, and treatment of hyperproliferative diseases, including tumor diseases.
Latest Patents
Edward holds 1 patent related to his invention titled "Inhibitors of HER3 activity." This patent describes a pharmaceutical composition that includes an active agent, specifically an anti-HER3-antibody. The invention aims to provide a therapeutic option for patients suffering from various tumor diseases.
Career Highlights
Edward is affiliated with the Max Planck Society for the Advancement of Science, where he conducts his research. His work at this prestigious institution has allowed him to explore innovative solutions in the pharmaceutical industry.
Collaborations
One of his notable collaborators is Axel Ullrich, with whom he has worked on advancing research in the field of cancer treatment.
Conclusion
Edward Htun-Van Der Horst is a dedicated inventor whose work in pharmaceutical compositions has the potential to impact the treatment of serious diseases. His contributions to the field are invaluable and highlight the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile